Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

rsz_john_isaac_colour.jpgIn this role John uses his drug discovery and scientific experience to identify and advance external opportunities in the areas of Alzheimer’s Disease and mood disorders. John’s scientific interests centre on synaptic mechanisms in circuit function, and how dysfunction causes psychiatric and neurological disease. John now co-leads the DPUK’s Synaptic health working group. He works closely with colleagues at the University of Cambridge in the New Therapeutics in Alzheimer’s Disease (NTAD) study, which is looking to identify sensitive and tractable neurophysiological biomarkers for next generation experimental medicine studies.

John is speaking in the ‘How DPUK helped me’ session.